Bosutinib monohydrate

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Min.Order :0
Purity: ≥95%

Keywords

Bosutinib hydrate 3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-, hydrate (1:1)

Quick Details

Appearance:Pale Yellow Solid
Application:For research use only.
PackAge:
ProductionCapacity:
Storage:Store at 2-8 °C
Transportation:

Superiority:

We provide customized and high-quality Bosutinib monohydrate product for your project.

Details:

Bosutinib hydrate is a Src/Abl inhibitor used in the treatment of chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow. Bosutinib is a tyrosine kinase inhibitor that works by blocking the activity of BCR-ABL, a protein that promotes the growth of abnormal leukemia cells in patients with CML. BCR-ABL is formed as a result of a genetic abnormality known as the Philadelphia chromosome. It is indicated for the treatment of adults with newly diagnosed chronic phase CML as well as CML that is resistant or intolerant to prior therapy, including imatinib.

View All